Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs KOPRAN. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES KOPRAN. ZYDUS LIFESCIENCES/
KOPRAN.
 
P/E (TTM) x 22.2 20.0 110.8% View Chart
P/BV x 4.8 2.2 222.7% View Chart
Dividend Yield % 0.3 1.4 23.1%  

Financials

 ZYDUS LIFESCIENCES   KOPRAN.
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-24
KOPRAN.
Mar-24
ZYDUS LIFESCIENCES/
KOPRAN.
5-Yr Chart
Click to enlarge
High Rs1,030292 352.3%   
Low Rs483110 440.3%   
Sales per share (Unadj.) Rs194.3127.5 152.4%  
Earnings per share (Unadj.) Rs38.110.6 360.2%  
Cash flow per share (Unadj.) Rs45.713.2 344.9%  
Dividends per share (Unadj.) Rs3.003.00 100.0%  
Avg Dividend yield %0.41.5 26.6%  
Book value per share (Unadj.) Rs197.1101.7 193.8%  
Shares outstanding (eoy) m1,006.2348.21 2,087.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.91.6 246.9%   
Avg P/E ratio x19.919.0 104.5%  
P/CF ratio (eoy) x16.615.2 109.1%  
Price / Book Value ratio x3.82.0 194.2%  
Dividend payout %7.928.4 27.8%   
Avg Mkt Cap Rs m761,0659,690 7,853.9%   
No. of employees `000NANA-   
Total wages/salary Rs m27,890523 5,334.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m195,4746,146 3,180.5%  
Other income Rs m3,694147 2,518.8%   
Total revenues Rs m199,1686,293 3,165.1%   
Gross profit Rs m52,848744 7,107.1%  
Depreciation Rs m7,641129 5,929.2%   
Interest Rs m81286 945.0%   
Profit before tax Rs m48,089675 7,119.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,775166 5,892.5%   
Profit after tax Rs m38,314510 7,519.0%  
Gross profit margin %27.012.1 223.5%  
Effective tax rate %20.324.6 82.8%   
Net profit margin %19.68.3 236.4%  
BALANCE SHEET DATA
Current assets Rs m114,1984,540 2,515.2%   
Current liabilities Rs m53,3972,185 2,443.5%   
Net working cap to sales %31.138.3 81.2%  
Current ratio x2.12.1 102.9%  
Inventory Days Days306 459.6%  
Debtors Days Days971,261 7.7%  
Net fixed assets Rs m161,3522,892 5,578.9%   
Share capital Rs m1,006482 208.7%   
"Free" reserves Rs m197,2894,420 4,463.5%   
Net worth Rs m198,2954,902 4,045.1%   
Long term debt Rs m0166 0.0%   
Total assets Rs m276,3667,432 3,718.4%  
Interest coverage x60.28.9 679.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.8 85.5%   
Return on assets %14.28.0 176.7%  
Return on equity %19.310.4 185.9%  
Return on capital %24.715.0 164.2%  
Exports to sales %43.044.4 97.0%   
Imports to sales %9.910.7 92.0%   
Exports (fob) Rs m84,1172,727 3,084.3%   
Imports (cif) Rs m19,274659 2,926.8%   
Fx inflow Rs m84,1172,727 3,084.3%   
Fx outflow Rs m19,274752 2,562.2%   
Net fx Rs m64,8431,975 3,283.1%   
CASH FLOW
From Operations Rs m32,279433 7,462.0%  
From Investments Rs m-14,752-436 3,387.2%  
From Financial Activity Rs m-18,10410 -183,053.6%  
Net Cashflow Rs m-7487 -10,762.6%  

Share Holding

Indian Promoters % 75.0 44.5 168.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.2 1.5 1,179.9%  
FIIs % 7.5 1.3 574.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 55.5 45.1%  
Shareholders   370,863 57,154 648.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs KOPRAN.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs KOPRAN. Share Price Performance

Period Cadila Healthcare KOPRAN. S&P BSE HEALTHCARE
1-Day 0.47% 9.99% 1.23%
1-Month -4.00% -22.87% -0.24%
1-Year 47.72% -18.58% 43.62%
3-Year CAGR 27.64% -1.23% 20.35%
5-Year CAGR 30.46% 44.76% 26.24%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the KOPRAN. share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of KOPRAN. the stake stands at 44.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of KOPRAN..

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 7.9%.

KOPRAN. paid Rs 3.0, and its dividend payout ratio stood at 28.4%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of KOPRAN..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.